| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/31/1996 | EP0723399A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
| 07/31/1996 | EP0647219B1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
| 07/31/1996 | EP0422175B1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
| 07/31/1996 | CN1128029A Thiazole derivatives as lipoxygenase inhibitors |
| 07/30/1996 | US5541325 Enzyme inhibitors, antiallergens |
| 07/30/1996 | US5541228 Melatonergic agents |
| 07/30/1996 | US5541219 Antiinflammatory agents; aids |
| 07/30/1996 | US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents |
| 07/30/1996 | US5541200 Piperidinyl thiacyclic derivatives |
| 07/30/1996 | US5541192 Treating restinosis |
| 07/30/1996 | US5541191 Treating pulmonary inflamation |
| 07/30/1996 | US5541183 Ginkgolide derivatives |
| 07/30/1996 | US5541164 Such as cladribine, to treat e.g. rheumatoid arthritis and multiple sclerosis |
| 07/30/1996 | US5540926 Gp39 protein |
| 07/30/1996 | US5540919 Method for enhancement of production of lymphokines and applications thereof |
| 07/30/1996 | CA2072509C Cyclosporin emulsion compositions for oral administration |
| 07/30/1996 | CA1338491C Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 07/25/1996 | WO1996022377A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | WO1996022373A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | WO1996022090A1 Green porphyrins as immunomodulators |
| 07/25/1996 | WO1996022068A2 Methods and pharmaceutical compositions employing desmethylselegiline |
| 07/25/1996 | WO1996022024A1 Receptor specific transepithelial transport of immunogens |
| 07/25/1996 | WO1996009805A3 Chitosan induced immunopotentiation |
| 07/25/1996 | CA2210997A1 Activation of t-cells by modified, antigenic immunoglobulins |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/24/1996 | WO1995003049A1 Methods of treating hiv with azaspiranes |
| 07/24/1996 | EP0723146A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722729A2 Aryl-substituted rhodanines for treating multiple sclerosis |
| 07/24/1996 | EP0722724A1 Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants |
| 07/24/1996 | EP0722723A2 Phenol derivatives for treating multiple sclerosis |
| 07/24/1996 | EP0722463A1 Methods and composition for the modulation of host immune response to allergens |
| 07/24/1996 | EP0722457A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 07/24/1996 | EP0722452A1 Nf-at polypeptides and polynucleotides |
| 07/24/1996 | EP0722448A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 07/24/1996 | EP0722438A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 07/24/1996 | EP0722342A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 07/24/1996 | EP0722341A1 Improvements in and relating to vaccines |
| 07/24/1996 | EP0722340A1 Immunological tolerance-inducing agent |
| 07/24/1996 | EP0722324A1 Pharmaceutical composition for immunoenhancement therapy |
| 07/24/1996 | EP0722322A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | CN1127301A A method for the resolution of a racemic mixture of nucleoside enantioners |
| 07/24/1996 | CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5538997 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| 07/23/1996 | US5538986 Tricyclic derivatives, compositions and methods of use |
| 07/23/1996 | US5538978 9-purinyl phosphonic acid derivatives |
| 07/23/1996 | US5538969 4-amino derivatives of 5-substituted mycophenolic acid |
| 07/23/1996 | US5538951 Dipeptides of glutamic acid and tryptophan for immunology |
| 07/23/1996 | US5538854 Method for the determination of predisposition to autoimmune disease |
| 07/23/1996 | US5538733 Poultry |
| 07/21/1996 | CA2167456A1 Use of l-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-a and other immunodeppresant drugs |
| 07/18/1996 | WO1996021724A1 Human deoxycytidine kinase 2 |
| 07/18/1996 | WO1996021663A1 IMIDAZO[4,5-c]QUINOLINE AMINES |
| 07/18/1996 | WO1996021661A1 Piperidine derivatives having tachykinin antagonist activity |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021466A1 Method to prevent transplant rejection |
| 07/18/1996 | WO1996021463A2 New applications of lysozyme dimer |
| 07/18/1996 | WO1996021458A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021435A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/18/1996 | WO1996006860A3 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2210091A1 New applications of lysozyme dimer |
| 07/18/1996 | CA2210088A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | CA2209125A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/17/1996 | EP0721504A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
| 07/17/1996 | EP0721469A1 Anti-gp39 antibodies and uses therefor |
| 07/17/1996 | EP0721351A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 07/17/1996 | EP0721347A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections |
| 07/17/1996 | EP0721346A1 Methods for inducing antigen-specific t cell tolerance |
| 07/17/1996 | EP0721345A1 Prostatic cancer vaccine |
| 07/17/1996 | EP0721342A1 The semaphorin gene family |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/17/1996 | EP0681470B1 Recombinant living subunit vaccine composition and process for its preparation |
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | CN1126995A Antiallergic imidazoazepines |
| 07/17/1996 | CN1126947A Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 07/16/1996 | US5536747 Enzyme inhibitors |
| 07/16/1996 | US5536730 Imidazonaphthyridine derivatives |
| 07/16/1996 | US5536729 Rapamycin formulations for oral administration |
| 07/16/1996 | US5536495 Proteins for organ rejection in tranplants |
| 07/16/1996 | CA2021338C Imidazoquinolone derivatives |
| 07/11/1996 | WO1996021015A2 Combination gene delivery vehicles |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020913A1 Novel trienoic retinoid compounds and methods |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 07/11/1996 | WO1996020705A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a) |